Chest Tube Drainage for Hemothorax
(HemoTxRCT Trial)
Trial Summary
What is the purpose of this trial?
This trial is studying two ways to treat patients with small to moderate amounts of blood in their chest after an injury. One method uses a chest tube to drain the blood, while the other involves closely monitoring the patient to see if the blood goes away on its own. The goal is to find out which method is better for patients.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Chest Tube Drainage for Hemothorax is an effective treatment?
The available research shows that chest tube drainage is effective for treating hemothorax. One study involving 1,845 patients with traumatic hemothorax found that using a protocol with early removal of the chest tube led to a hospital stay of 48 hours or less for 81.8% of patients. Only 8.1% needed further surgery, and severe complications were rare, occurring in just 2.2% of cases. This suggests that chest tube drainage is a reliable treatment for hemothorax, helping most patients recover quickly with minimal complications.12345
What safety data is available for chest tube drainage for hemothorax?
Chest tube drainage, also known as tube thoracostomy, is a common procedure used to treat conditions like hemothorax. Safety data indicates that complications can occur in 2-25% of cases, with serious complications in up to 10% of cases. Complications can be technical, such as tube malposition or dislodgement, and infective, such as empyema. The blunt dissection technique is recommended over the trocar technique due to a lower risk of complications. Proper securing of the tube connection is important to prevent dislodgement and associated risks.678910
Is the treatment 'Chest tube drain' promising for hemothorax?
Research Team
Chad G Ball, MD
Principal Investigator
University of Calgary
Eligibility Criteria
This trial is for adults over 18 with blunt chest injuries and a hemothorax detected by CT scan. It's not for those who are unstable due to the injury, need urgent tube placement, have penetrating injuries, already have a chest tube, were admitted over 24 hours ago, or have severe chest fractures or respiratory distress from the hemothorax.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either chest tube drainage or expectant management for traumatic hemothorax
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Chest tube drain (Tube Thoracostomy)
- Expectant management (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Dr. Shweta Patel
University of Calgary
Chief Medical Officer since 2020
MD from the University of Baroda Medical College, India
Dr. Edward McCauley
University of Calgary
President and Vice-Chancellor since 2018
PhD in Ecology and Evolutionary Biology from the University of California, Santa Barbara
Alberta Health services
Collaborator
Dr. Verna Yiu
Alberta Health services
Chief Medical Officer
MD
Andre Tremblay
Alberta Health services
Chief Executive Officer
Bachelor's degree in a relevant field